Renal replacement therapy for acute renal injury: We need better therapy

Contributions to Nephrology

Volumn 174, Issue , 2011, Pages 242-251

  Demirjian, Savag G ^a   Paganini, Emil P ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Propags Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; ECONOMICS; HUMAN; METHODOLOGY; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; HUMANS; RENAL REPLACEMENT THERAPY;

EID: 84925852258     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000329402     Document Type: Article

References (29)

1. Hickman RO, Scribner BH: Application of the pumpless hemodialysis system to infants and children. Trans Am Soc Artif Intern Organs 1962;8:309-314.
2. Scribner BH: Role of the artificial kidney in management of acute renal failure. Northwest Med 1959;58: 555-559.
3. Gotch FA, Sargent JA, Keen ML, Lee M: Individualized, quantified dialysis therapy of uremia. Proc Clin Dial Transplant Forum 1974;4:27-35.
4. Sargent J, Gotch F, Borah M, Piercy L, Spinozzi N, Schoenfeld P, Humphreys M: Urea Kinetics: a guide to nutritional management of renal failure. Am J Clin Nutr 1978;31:1696-702. (Pubitemid 9034114)
5. Levine J, Bernard DB: The role of urea kinetic modeling, TACurea, and Kt/V in achieving optimal dialysis: a critical reappraisal. Am J Kidney Dis 1990;15: 285-301. (Pubitemid 20257465)
6. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20. (Pubitemid 351931092)
7. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S: Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med 2009;361:1627-1638.
8. Unruh M, Benz R, Greene T, Yan G, Beddhu S, DeVita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm- McGillicuddy J, Teehan BP, Meyer KB, Hemo Study Group: Effects of hemodialysis dose and membrane flux on health- related quality of life in the HEMO study. Kidney Int 2004;66:355-366. (Pubitemid 38870113)
9. Macedo E, Mehta RL: Early vs late start of dialysis: it's all about timing. Crit Care 2010;14:112.
10. Gibney RT, Bagshaw SM, Kutsogiannis DJ, Johnson C: When should renal replacement therapy for acute kidney injury be initiated and discontinued? Blood Purif 2008;26:473-484.
11. Devarajan P: Review: neutrophil gelatinaseassociated lipocalin: a troponin- like biomarker for human acute kidney injury. Nephrology 2010;15:419-428.
12. Tuladhar SM, Puntmann VO, Soni M, Punjabi PP, Bogle RG: Rapid detection of acute kidney injury by plasma and urinary neutrophil gelantinase- associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol 2009;53:261-266.
13. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008;3:665-673.
14. Thakar CV, Yared JP, Worley S, Cotman K, Paganini EP: Renal dysfunction and serious infection after open- heart surgery. Kidney Int 2003;64:239-246. (Pubitemid 36714177)
15. Jiang M, Dong Z: Regulation and pathological role of p53 in cisplatin nephrotoxicity. J Pharmacol Exp Ther 2008;327:300-307.
16. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hatden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL: Comparison of two fluid- management strategies in acute lung injury. N Engl J Med 2006;354:2564-2575. (Pubitemid 43882352)
17. Btaiche IF, Mohammad RA, Alaniz C, Mueller BA: Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy. Pharmacotherapy 2008;28:600-613. (Pubitemid 351620029)
18. Cruz DN, Antonelli M, Fumagalli R, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445-2452.
19. Antonelli M, Fumagalli R, Cruz DN, Brienza N, Giunta F, EUPHAS Study Group: PMX Endotoxin Removal in the clinical practice: esults from the EUPHAS Trial; in Ronco C, Piccinni P, Rosner MH: Endotoxemia and Endotoxin Shock: Disease, Diagnosis and Therapy. Contrib Nephrol. Basel, Karger, 2010, vol 167, pp 83- 90.
20. Ronco C, Brendolan A, Dan M, Piccinni P, Bellomo R, DeNitti C, Inguaggiato P, Tetta C: Adsorption in sepsis. Kidney Int Suppl 2000;76:S148-S155. (Pubitemid 30612815)
21. Peng Z, Singbartl K, Simon P, Rimmele T, Bishop J, Clermont G, Kellum JA: Blood purification in sepsis: a new paradigm; in Ronco C, Bellomo R, McCullough PA (eds): Cardiorenal Syndromes in Critical Care. Contrib Nephrol. Basel, Karger, 2010, vol 165, pp 322- 328.
22. Kimmel JD, Gibson GA, Watkins SC, Kellum JA, Federspiel WJ: IL- 6 adsorption dynamics in hemoadsorption beads studied using confocal laser scanning microscopy. J Biomed Mater Res B Appl Biomater 2010;92:390-396.
23. Ronco C, Piccinni P, Kellum J: Rationale of extracorporeal removal of endotoxin in sepsis: theory, timing and technique; in Ronco C, Piccinni P, Rosner MH (eds): Endotoxemia and Endotoxin Shock: Disease, Diagnosis and Therapy. Contrib Nephrol. Basel, Karger, 2010, vol 167, pp 25- 34.
24. Bellomo R, Tetta C, Ronco C: Coupled plasma filtration adsorption. Intensive Care Med 2003;29:1222-1228. (Pubitemid 37041147)
25. Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, Sobota J: Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004;66:1578-1588. (Pubitemid 39298393)
26. Ding F, Humes HD: The bioartificial kidney and bioengineered membranes in acute kidney injury. Nephron Exp Nephrol 2008;109:118-122.
27. Muthusubramaniam L, Lowe R, Fissell WH, Li L, Marchant RE, Desai TA, Roy S: Hemocompatibility of silicon- based substrates for biomedical implant applications. Ann Biomed Eng 2011;39:1296-1305.
28. Li L, Marchant RE, Dubnisheva A, Roy S, Fissell WH: Anti- biofouling sulfobetaine polymer thin films on silicon and silicon nanopore membranes. J Biomater Sci Polym Ed 2010, E- pub ahead of print.
29. Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA, BEST Kidney Investigators: Cost of acute renal replacement therapy in the intensive care unit: results from the Beginning and Ending Supportive Therapy for the Kidney (BEST KIDNEY) study. Crit Care 2010;14:R46.